Share this article
Pharma Giant Tests IBM Blockchain in Bid to Improve Clinical Trials
Pharma giant Boehringer Ingelheim is set to trial IBM blockchain in Canada to raise the quality of processes and records in clinical trials.
Updated Dec 12, 2022, 12:42 p.m. Published Feb 13, 2019, 9:00 a.m.
